$2.87
3.69% yesterday
Nasdaq, Dec 30, 09:45 pm CET
ISIN
US14757U1097
Symbol
CASI
Sector
Industry

CASI Pharmaceuticals Inc Target price 2024 - Analyst rating & recommendation

CASI Pharmaceuticals Inc Classifications & Recommendation:

Buy
100%

CASI Pharmaceuticals Inc Price Target

Target Price $6.00
Price $2.93
Potential
Number of Estimates 1
1 Analyst has issued a CASI Pharmaceuticals Inc price target 2025. The average CASI Pharmaceuticals Inc target price is $6.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend CASI Pharmaceuticals Inc to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CASI Pharmaceuticals Inc stock has an average upside potential 2025 of . Most analysts recommend the CASI Pharmaceuticals Inc stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Revenue Million $ 33.88 19.80
10.96% 41.57%
Net Margin -79.89% -102.22%
24.63% 27.94%

1 Analyst has issued a sales forecast CASI Pharmaceuticals Inc 2024 . The average CASI Pharmaceuticals Inc sales estimate is

$19.8m
Unlock
. This is
6.93% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$19.8m 6.93%
Unlock
, the lowest is
$19.8m 6.93%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $33.9m 10.96%
2024
$19.8m 41.57%
Unlock
2025
$46.5m 134.79%
Unlock
2026
$70.4m 51.37%
Unlock
2027
$89.5m 27.17%
Unlock
2028
$108m 20.80%
Unlock

The average CASI Pharmaceuticals Inc net profit estimate is

$-20.2m
Unlock
. This is
32.00% higher
Unlock
than the net profit for the last 12 months(TTM).

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-27.1m 32.89%
2024
$-20.2m 25.26%
Unlock
2025
$-15.5m 23.18%
Unlock

Net Margin

2023 -79.89% 24.63%
2024
-102.22% 27.94%
Unlock
2025
-33.44% 67.29%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Dec '23 2024
Estimates
Earnings Per Share $ -2.02 -1.51
32.89% 25.25%
P/E negative
EV/Sales 4.69

The average CASI Pharmaceuticals Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.51
Unlock
. This is
31.98% higher
Unlock
than earnings per share in the financial year 2023.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-2.02 32.89%
2024
$-1.51 25.25%
Unlock
2025
$-1.16 23.18%
Unlock

P/E ratio

Current -1.34 58.64%
2024
-4.30 220.90%
Unlock
2025
-5.60 30.23%
Unlock

Based on analysts' sales estimates for 2024, the CASI Pharmaceuticals Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.80 12.20%
2024
4.69 160.59%
Unlock
2025
2.00 57.41%
Unlock
2026
1.32 33.94%
Unlock
2027
1.04 21.36%
Unlock
2028
0.86 17.23%
Unlock

P/S ratio

Current 1.88 18.58%
2024
4.40 134.35%
Unlock
2025
1.87 57.41%
Unlock
2026
1.24 33.94%
Unlock
2027
0.97 21.36%
Unlock
2028
0.81 17.22%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today